Optimization of a plasma rich in growth factors membrane for the treatment of inflammatory ocular diseases

dc.contributor.author	Anitúa, Eduardo
dc.contributor.author	Fuente, María
dc.contributor.author	Merayo Lloves, Jesús
dc.contributor.author	Muruzábal, Francisco
dc.date.accessioned	2023-03-15T10:35:28Z
dc.date.available	2023-03-15T10:35:28Z
dc.date.issued	2022
dc.identifier.citation	Bioengineering, 9(10) (2022); doi:10.3390/bioengineering9100508
dc.identifier.issn	2306-5354
dc.identifier.uri	http://hdl.handle.net/10651/67193
dc.description.sponsorship	HAZITEK program of the Department of Economic Development and Infrastructure of the Basque Country Government [ZL-2017/00303 y ZL-2018/00154]
dc.language.iso	eng
dc.relation.ispartof	Bioengineering
dc.rights	© 2022 Los autores
dc.rights	CC Reconocimiento 4.0 Internacional
dc.rights.uri	http://creativecommons.org/licenses/by/4.0/
dc.source	Scopus
dc.source.uri	https://www.scopus.com/inward/record.uri?eid=2-s2.0-85140448990&doi=10.3390%2fbioengineering9100508&partnerID=40&md5=0e91f5ed8c2c2c58c61595daed26b251
dc.title	Optimization of a plasma rich in growth factors membrane for the treatment of inflammatory ocular diseases
dc.type	journal article
dc.identifier.doi	10.3390/bioengineering9100508
dc.relation.publisherversion	http://dx.doi.org/10.3390/bioengineering9100508
dc.rights.accessRights	open access
dc.type.hasVersion	VoR

Este ítem está sujeto a una licencia Creative Commons